Evidence map›Paper›PMID 23845988›Full record

ArticleBiochimica et biophysica acta2013

ErbB4 is an upstream regulator of TTF-1 fetal mouse lung type II cell development in vitro.

Katja Zscheppang, Ulrike Giese, Stefan Hoenzke, Dorothea Wiegel, Christiane E L Dammann

Open access · greenAbstract read
In one paragraph

Article in Biochimica et biophysica acta, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Katja ZscheppangDepartment of Pediatrics, Hannover Medical School, Hannover 30625, Germany; Division of Newborn Medicine, Floating Hospital for Children at Tufts Medical Center, Boston, MA 02111, USA.
Ulrike GieseDepartment of Pediatrics, Hannover Medical School, Hannover 30625, Germany.
Stefan HoenzkeDivision of Newborn Medicine, Floating Hospital for Children at Tufts Medical Center, Boston, MA 02111, USA.
Dorothea WiegelDepartment of Pediatrics, Hannover Medical School, Hannover 30625, Germany; Division of Newborn Medicine, Floating Hospital for Children at Tufts Medical Center, Boston, MA 02111, USA.
Christiane E L DammannDepartment of Pediatrics, Hannover Medical School, Hannover 30625, Germany; Division of Newborn Medicine, Floating Hospital for Children at Tufts Medical Center, Boston, MA 02111, USA; Sackler School for Graduate Biomedical Sciences, Tufts University, Boston, MA 02111, USA. Electronic address: cdammann@tuftsmedicalcenter.org.
Tufts Children's Hospital · USMedizinische Hochschule Hannover · DETufts Medical Center · USTufts University · US

Funding

ErbB Signaling in Fetal Type II Cell GrowthR01HL085648 · NHLBI · TUFTS MEDICAL CENTER · PI DAMMANN, CHRISTIANE E, NIELSEN, HEBER C. · 2009 to 2012
$1.6M
NHLBI NIH HHS HL-85648NHLBI NIH HHS R01 HL085648
6 · The paper itself

Abstract

TTF-1 is an important transcription factor in lung development and lung disease and is essential for lung cell differentiation, specifically surfactant protein (Sftp) expression. The molecular mechanisms that drive the expression and transcriptional control of TTF-1 are not fully understood. In the fetal lung, ErbB4 functions as a transcriptional co-factor and regulates the timely onset of fetal Sftp expression. We speculate that ErbB4 is an upstream regulator of TTF-1 and regulates Sftpb expression via this pathway in alveolar type II cells. Neuregulin-induced ErbB4 and TTF-1 signaling interactions were studied by co-immunoprecipitation and confocal microscopy. Overexpression of ErbB4 and TTF-1 was analyzed in its effect on cell viability, Sftpb expression, TTF-1 expression, and Sftpb and TTF-1 promoter activity. The effect of ErbB4 deletion and ErbB4 nuclear translocation on TTF-1 expression was studied in primary fetal type II epithelial cells, isolated from transgenic HER4(heart(-/-)) mice. ErbB4 ligand neuregulin induces ErbB4 and TTF-1 co-precipitation and nuclear colocalization. Combined ErbB4 and TTF-1 overexpression inhibits cell viability, while promoting Sftpb expression more than single overexpression of each protein. NRG stimulates TTF-1 expression in ErbB4-overexpressing epithelial cells, while this effect is absent in ErbB4-depleted cells. In primary fetal type II cells, ErbB4 nuclear translocation is critical for its regulation of TTF-1-induced Sftpb upregulation. TTF-1 overexpression did not overcome this important requirement. We conclude that ErbB4 is a critical upstream regulator of TTF-1 in type II epithelial cells and that this interaction is important for Sftpb regulation.

Indexed as

Alveolar Epithelial CellsAnimalsCell LineCell NucleusCell SurvivalDNA-Binding ProteinsErbB ReceptorsFetusGene Expression Regulation, DevelopmentalHumansImmunoprecipitationMiceModels, BiologicalNeuregulinsPromoter Regions, GeneticProtein Structure, TertiaryDNA-Binding ProteinsERBB4 protein, humanErbb4 protein, mouseErbB ReceptorsNeuregulinsPulmonary Surfactant-Associated Protein BReceptor, ErbB-4RNA, MessengerTranscription FactorsTtf1 protein, mouseLung developmentNeuregulinSurfactantType II cell

Identifiers

PMID23845988
PMCPMC3835615
OpenAlexW1981546895

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.